WELL Health Completes $70 Million Bought Deal Offering of Convertible Debentures

November 25, 2021

WELL Health Technologies Corp. (TSX: WELL) completed an oversubscribed bought deal prospectus supplement offering of convertible senior unsecured debentures for gross proceeds of $70 million, including debentures issued pursuant to the exercise in full of the underwriters' over-allotment option. Eight Capital and Scotiabank acted as joint bookrunners of the offering, together with a syndicate of underwriters that also included Stifel GMP as co-lead underwriter and Canaccord Genuity Corp., CIBC World Markets Inc., Desjardins Securities Inc., Laurentian Bank Securities Inc., TD Securities Inc., Beacon Securities Limited, Echelon Wealth Partners Inc., Haywood Securities Inc., Paradigm Capital Inc. and PI Financial Corp.

WELL is a technology enabled healthcare company whose overarching objective is to positively impact health outcomes to empower and support healthcare practitioners and their patients. WELL has built an innovative practitioner enablement platform that includes comprehensive end to end practice management tools inclusive of virtual care and digital patient engagement capabilities as well as Electronic Medical Records (EMR), Revenue Cycle Management (RCM) and data protection services. WELL uses this platform to power healthcare practitioners both inside and outside of WELL's own omni-channel patient service offerings. WELL owns and operates Canada's largest network of outpatient medical clinics serving primary and specialized healthcare services and is the provider of a leading multi-national multi-disciplinary telehealth offering.

Wildeboer Dellelce LLP acted for the underwriters in connection with the offering with a team comprised of Perry Dellelce, Michael Rennie, Carlye Bellavia, Natalie Tershakowec and Emma Weiss (corporate/securities) and Katy Pitch and Marija Tasevska (tax).